People with AIDS also have HIV, as HIV is the first stage of AIDS. Learn about the differences, how the conditions overlap, ...

Efavirenz, an HIV drug, shows potential for treating chikungunya virus, inhibiting replication and reducing viral load ...

An annual injection designed to guard against Human Immunodeficiency Virus (HIV) has completed an important early safety ...

HIV prevention has advanced with lenacapavir, a yearly injection that blocks the virus's replication, providing long-term ...

The drug, which works by blocking HIV from entering and multiplying in human cells, remained in the body for at least 56 ...

For the majority of people with the virus in the U.S., dying with HIV has turned into living a long life with HIV.

Discover why starting HIV treatment promptly preserves immune function, prevents transmission, improves quality of life and reduces costs ...

A group of leading African researchers trying to develop effective vaccines against HIV is trying to figure out how to ...

Bay Area drug giant Gilead is plotting the trial of a groundbreaking, once-a-year HIV prevention drug lenacapavir.

However, hope may be on the horizon as a radical new drug has potential to be released if it passes all trials. Lenacapavir, ...

Lenacapavir stops the virus from replicating inside cells. If future trials go well ... Global Fund and Joint United Nations Programme on HIV and Aids (UNAids) are all working on strategies ...